“investing” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
Applied Molecular Plots IPO to Back Transport of Biologic Drugs to Gut 05/20/20 San Francisco
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs 05/08/20 National
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
BridgeBio’s Pipeline Expansion Continues as Portfolio’s Milestones Approach 04/30/20 San Francisco
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle 04/23/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs 04/17/20 Texas
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
Blackstone Pays Alnylam $1B to Grab a Stake in RNAi Drug Inclisiran 04/13/20 Boston
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests 04/08/20 Boston
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials 04/03/20 New York
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Page 2 of 25 « previous page · next page »